{"id":1666,"date":"2023-01-30T15:00:19","date_gmt":"2023-01-30T15:00:19","guid":{"rendered":"https:\/\/blogs.bmj.com\/tc\/?p=1666"},"modified":"2023-01-27T12:04:00","modified_gmt":"2023-01-27T12:04:00","slug":"goodbye-pmi-philip-morris-removed-from-canadian-covid-19-vaccine-collaboration","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/tc\/2023\/01\/30\/goodbye-pmi-philip-morris-removed-from-canadian-covid-19-vaccine-collaboration\/","title":{"rendered":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration"},"content":{"rendered":"<p><strong>Les Hagen and Daniel Dorado<\/strong><\/p>\n<p>Tobacco giant Philip Morris (PMI) was recently removed from Canada\u2019s Medicago Inc vaccine collaboration following a determined two-year global advocacy campaign led by <a href=\"https:\/\/www.ash.ca\/\">ASH Canada<\/a> and <a href=\"https:\/\/www.corporateaccountability.org\/\">Corporate Accountability<\/a><u> (CAI)<\/u>. This development represents an enormous win for global public health, ensuring that the control of one pandemic doesn\u2019t compromise that of another.<\/p>\n<p>The news of the expulsion was conspicuously leaked out through a Quebec <a href=\"https:\/\/www.lesoleil.com\/2022\/12\/23\/medicago-saffranchit-du-tabac-mais-lavenir-reste-embrume-29b4c1592048c6bc2f6a9e63541d3796\">French-language newspaper<\/a> on Christmas Eve, likely in an effort to suppress news coverage of the decision. Anticipating this possibility, the lead advocacy organisations (ASH and CAI) quickly issued a multi-language <a href=\"https:\/\/www.prnewswire.com\/news-releases\/tobacco-giant-ejected-from-canadian-covid-19-vaccine-collaboration-301709989.html\">news release<\/a> to publicise the decision globally through various news services and social media platforms.<\/p>\n<p>The PMI removal follows the World Health Organization\u2019s (WHO) March 2022 <a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-who-medicago-covid-19-vaccine\/\">decision<\/a> to refuse Medicago\u2019s application for global distribution of the vaccine through the COVAX distribution system. The involvement of PMI was cited as the primary reason for the decision. The Canadian government-backed collaboration represented a blatant contravention of <a href=\"https:\/\/fctc.who.int\/publications\/m\/item\/good-country-practices-in-the-implementation-of-who-fctc-article-5.3-and-its-guidelines\">Article 5.3<\/a> of the Framework Convention on Tobacco Control (FCTC), which requires Governments to protect public policies from the vested interests of the tobacco industry. Subsequently, at the World Health Assembly in May 2022, WHO member states were <a href=\"https:\/\/www.corporateaccountability.org\/media\/canada-stop-pmi-covid-19-vaccine\/\">formally advised<\/a> to refuse accepting or distributing the \u201cPhilip Morris vaccine.\u201d<\/p>\n<p>The removal of PMI from the Medicago vaccine consortium is a victory for public health and for the WHO FCTC in particular. The government of Canada invested <a href=\"https:\/\/pm.gc.ca\/en\/news\/news-releases\/2020\/10\/23\/prime-minister-announces-funding-advance-development-canadian-covid\">US$130 million<\/a> in the vaccine collaboration despite knowing that PMI was a major investor and that this relationship could contravene Article 5.3 of the treaty. Article 5.3 is a cornerstone of the FCTC and tobacco industry interference is regarded as the <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789241597340\">single largest barrier<\/a> to the effective implementation of the treaty.<\/p>\n<p>Ironically, the Canadian government championed a <a href=\"https:\/\/fctc.who.int\/publications\/m\/item\/fctc-cop8(12)-maximizing-transparency-of-delegations-from-parties-and-observers-to-the-conference-of-the-parties-its-subsidiary-bodies-and-other-who-fctc-meetings\">decision<\/a> at the 8th Conference of the Parties of the FCTC in 2018 urging all participating countries to comply with Article 5.3 and its guidelines. Unfortunately, the Canadian government did not follow its own directive and the absence of government-wide guidelines enabled the PMI collaboration.<\/p>\n<p>Canada is viewed as a world leader in tobacco control. If the Canadian government is vulnerable to tobacco industry engagement and collaboration, then so are many governments. All FCTC treaty participants need to fully implement Article 5.3 and its guidelines and the Canadian government needs to follow its own directive by closing the door on any future collaborations with tobacco corporations.<\/p>\n<p>In addition, governments need to implement other protective articles of the convention such as Article 19, which gives governments the power to sue Big Tobacco for its negligence, deception and public health damages. This action needs to be taken rapidly to hold the industry accountable and deter further misconduct.<\/p>\n<p>The civil society advocacy campaign to expel PMI involved publicity efforts, a social media campaign, numerous presentations and meetings with key stakeholders, targeted letter-writing, a pivotal appeal to the members of the World Health Assembly and various governments and regulatory agencies such as the Food and Drug Administration (FDA).<\/p>\n<p>Over 100 members of the Framework Convention Alliance (now the Global Alliance for Tobacco Control or GATC) participated in the advocacy campaign, including several who publicly urged their national governments to refuse accepting the \u2018Philip Morris vaccine\u2019. We are very grateful for the assistance, guidance and support of over 100 organisational members of the GATC who participated in the advocacy campaign, especially the Global Center for Good Governance in Tobacco Control (GGTC) and STOP (Stopping Tobacco Organizations and Products).<\/p>\n<p>Organisations were deeply concerned about PMI exploiting the COVID-19 pandemic for commercial gain while perpetuating the greatest industry-driven epidemic of our time. Tobacco use is responsible for over eight million deaths globally each year and PMI products are a significant contributor to the enormous human toll of disease, suffering, and death.<\/p>\n<p>This concern was apparently lost on the Canadian government which <a href=\"https:\/\/www.cbc.ca\/news\/health\/canada-covid-19-vaccine-medicago-who-approval-1.6403926\">argued to the end<\/a> that the PMI collaboration did not represent a treaty violation. However the government\u2019s messaging conflicted sharply with the WHO&#8217;s decision to refuse global distribution of the vaccine. The WHO\u2019s widely publicised decision to refuse global distribution of the vaccine was pivotal and made it untenable for the vaccine to gain approval until after PMI was removed.<\/p>\n<p>We applaud the WHO, the FCTC Secretariat, the Tobacco-Free Initiative, and the Pan American Health Organization for vigorously defending and upholding the treaty and the WHO\u2019s organisational <a href=\"https:\/\/www.paho.org\/en\/documents\/tobacco-arms-related-disclosure-statement-non-state-actors\">policy<\/a> to reject tobacco industry partnerships. This policy extends to organisations that are in official relations with the WHO including Gavi, the vaccine alliance which oversees the COVAX vaccine distribution system.<\/p>\n<p>It cannot be overstated: the expulsion of PMI from Canada\u2019s vaccine collaboration is a major victory for the global public health, the WHO FCTC, and the tobacco control community. We should all celebrate this momentous achievement. Goodbye, PMI.<\/p>\n<p><em><strong>Les Hagen<\/strong> is the Executive Director of ASH (Action on Smoking and Health) Canada.\u00a0<strong>Daniel Dorado<\/strong> is the Tobacco Campaign Director for Corporate Accountability USA.<\/em><\/p>\n<p>&nbsp;<\/p>\n<table width=\"0\">\n<tbody>\n<tr>\n<td width=\"132\"><\/td>\n<td width=\"255\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les Hagen and Daniel Dorado Tobacco giant Philip Morris (PMI) was recently removed from Canada\u2019s Medicago Inc vaccine collaboration following a determined two-year global advocacy campaign led by ASH Canada and Corporate Accountability (CAI). This development represents an enormous win for global public health, ensuring that the control of one pandemic doesn\u2019t compromise that of [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/tc\/2023\/01\/30\/goodbye-pmi-philip-morris-removed-from-canadian-covid-19-vaccine-collaboration\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":459,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1666","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/tc\/?p=1666\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control\" \/>\n<meta property=\"og:description\" content=\"Les Hagen and Daniel Dorado Tobacco giant Philip Morris (PMI) was recently removed from Canada\u2019s Medicago Inc vaccine collaboration following a determined two-year global advocacy campaign led by ASH Canada and Corporate Accountability (CAI). This development represents an enormous win for global public health, ensuring that the control of one pandemic doesn\u2019t compromise that of [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/tc\/?p=1666\" \/>\n<meta property=\"og:site_name\" content=\"Blog - Tobacco Control\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-30T15:00:19+00:00\" \/>\n<meta name=\"author\" content=\"Karen Evans-Reeves\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karen Evans-Reeves\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666\"},\"author\":{\"name\":\"Karen Evans-Reeves\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/person\\\/54532df55adae21b94895af061aca282\"},\"headline\":\"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration\",\"datePublished\":\"2023-01-30T15:00:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666\"},\"wordCount\":829,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666\",\"name\":\"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#website\"},\"datePublished\":\"2023-01-30T15:00:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?p=1666#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\",\"name\":\"Blog - Tobacco Control\",\"description\":\"A space to discuss the wider issues of tobacco control beyond the journal.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\",\"name\":\"Blog - Tobacco Control\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/files\\\/2017\\\/10\\\/blog-logo-tobacco-control.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/files\\\/2017\\\/10\\\/blog-logo-tobacco-control.png\",\"width\":255,\"height\":34,\"caption\":\"Blog - Tobacco Control\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/person\\\/54532df55adae21b94895af061aca282\",\"name\":\"Karen Evans-Reeves\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g\",\"caption\":\"Karen Evans-Reeves\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/author\\\/kevansreeves\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/tc\/?p=1666","og_locale":"en_US","og_type":"article","og_title":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control","og_description":"Les Hagen and Daniel Dorado Tobacco giant Philip Morris (PMI) was recently removed from Canada\u2019s Medicago Inc vaccine collaboration following a determined two-year global advocacy campaign led by ASH Canada and Corporate Accountability (CAI). This development represents an enormous win for global public health, ensuring that the control of one pandemic doesn\u2019t compromise that of [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/tc\/?p=1666","og_site_name":"Blog - Tobacco Control","article_published_time":"2023-01-30T15:00:19+00:00","author":"Karen Evans-Reeves","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karen Evans-Reeves","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666"},"author":{"name":"Karen Evans-Reeves","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/person\/54532df55adae21b94895af061aca282"},"headline":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration","datePublished":"2023-01-30T15:00:19+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666"},"wordCount":829,"publisher":{"@id":"https:\/\/blogs.bmj.com\/tc\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666","url":"https:\/\/blogs.bmj.com\/tc\/?p=1666","name":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration - Blog - Tobacco Control","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/tc\/#website"},"datePublished":"2023-01-30T15:00:19+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/tc\/?p=1666"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/tc\/?p=1666#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/tc\/"},{"@type":"ListItem","position":2,"name":"Goodbye, PMI. Philip Morris removed from Canadian COVID-19 vaccine collaboration"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/tc\/#website","url":"https:\/\/blogs.bmj.com\/tc\/","name":"Blog - Tobacco Control","description":"A space to discuss the wider issues of tobacco control beyond the journal.","publisher":{"@id":"https:\/\/blogs.bmj.com\/tc\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/tc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/tc\/#organization","name":"Blog - Tobacco Control","url":"https:\/\/blogs.bmj.com\/tc\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/tc\/files\/2017\/10\/blog-logo-tobacco-control.png","contentUrl":"https:\/\/blogs.bmj.com\/tc\/files\/2017\/10\/blog-logo-tobacco-control.png","width":255,"height":34,"caption":"Blog - Tobacco Control"},"image":{"@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/person\/54532df55adae21b94895af061aca282","name":"Karen Evans-Reeves","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8e72946f082639f0b9a86f6061c5de143826588afd385491c0a2468d171c670?s=96&d=mm&r=g","caption":"Karen Evans-Reeves"},"url":"https:\/\/blogs.bmj.com\/tc\/author\/kevansreeves\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/users\/459"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/comments?post=1666"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1666\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/media?parent=1666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/categories?post=1666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/tags?post=1666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}